Differences in Cleanroom Specifications between FDA and EU GMP

Introduction

One of the biggest debates between the cleanroom regulatory requirements of the FDA (2004) and the EU GMP (2022) is the difference in Pre-Use Post-Sterilization Integrity Testing (PUPSIT) requirements. It is a test that ensures the filter is undamaged after the sterilization process but before use. The FDA allows bypassing the test with solid justification, while the EU mandates it. The result can have a direct impact on the cleanroom capital and maintenance costs. It is one of the many differences that these two regulations have for cleanrooms, and we will explore each of them.

A modular and prefabricated cleanroom solution is the ultimate go-to choice for global pharmaceutical and medical device markets. A manufacturer of these structures needs to follow two major sets of rules to ensure they can export their product worldwide: FDA cGMP and EU GMP Annex 1. The core difference in these two approaches is:

• FDA Approach: FDA relies heavily on the ISO 14644 classes. They require full operational conditions with people and machinery working inside during testing.
• EU Approach: The European regulations are much stricter. They require testing at rest and in operation across all grades.

This article will help readers understand these cleanroom differences in an easy to understand manner. To ensure compliance, builders need to deeply understand the differences in HVAC, filtration, airflow, physical building materials, and layout. We will explain each of them while providing references for manufacturers, buyers, and businesses.

Cleanroom HVAC

Air Pressure and Volume

FDA requires that the difference in pressure between connected rooms should be 10-15 Pa positive deltaP when the doors are closed. The pressure needs to be monitored continuously and provide real-time alarms for deviations.

European rules suggest a lower baseline with a minimum of 10 Pa pressure difference between two adjacent rooms. Monitoring pressure difference and tracking are dependent on the facility's own risk management plan as defined in the site- specific Contamination Control Strategy (CCS). Another thing that the 2022 European rules specify is the risk-based control. They mention that if the facility wants to delay an alarm, they should provide a documented justification for any alarm delay setting.

Air Movement during Setup

During initial testing and qualification, both agencies set different importance on mapping the air. For air movement European standard emphasizes mapping the pressure cascade for visualization. It is mandatory to ensure that the dirty air does not sneak into a corner (ingress) when someone enters or exits the room. In comparison, the FDA is less strict and does not require specific visual proof.

Enclosed Barrier System

In the case of a fully enclosed workstation for sterile processing, both regulations deviate from each other. The FDA provides a more flexible approach. They allow an internal pressure of 17.5Pa to 50Pa overpressure compared to the surrounding environment. In comparison, EU regulation requires that the cleanroom be placed in a Grade C or D environment. It should also justify the facilities CCS assessment.

Air Refresh Rates

FDA requires a strict minimum of 20 air changes per hour (ACH) for ISO 8 supporting areas. It increases as the ISO rating increases to ISO 5/7. EU GMP does not fix any number to change the cleanroom volume per hour. It requires tests for airflow pattern validations. These include HVAC qualification per Annex 15 and ISO 14644. It requires the cleanroom to clear out particles in 20 minutes after the operation.

Energy and Upkeep

The newest ISO 14644-4:2022 standard for medical device and pharma design introduces methods to save power for HVAC systems. It consists of life-cycle maintenance checklists. Modern clean room manufacturing companies are adopting them rapidly to build better facilities.

Proactive vs. Reactive Approach

The FDA is reactive, the EU is proactive in the analysis of pressure patterns in cleanroom structures. The EU requires trend analysis of pressure data for continuous improvement. The FDA uses the traditional approach of resting when an alarm is sounded to find what's wrong.

Cleanroom Filtration

Efficiency and Leak Testing

Both regulations require the use of high efficiency particulate air (HEPA) filters. They capture at least 99.97% of the particles that are as small as 0.3 micrometers. Their testing method varies between regulations. FDA requires leak testing (DOP/PAO aerosol) when the filter is first put into operation and every six months for aseptic areas. The EU requires testing the filter twice a year, but requires extra testing if there is a system interruption.

Managing Gases and Microbial Data

For compressed gaseous and lyophilizer vacuum breaks, the FDA requires water-repelling filters and regular checkups. EU GMP requires the same strictness for all gases that come in contact with Grade A / B cleanroom surfaces. For microbial tracking, the EU requires comparison of historical data and modern data for alignment. The microbial tracking is not explicitly stated in the FDA guidelines.

Long-Term Efficiency

For modular cleanroom design, the FDA accepts ISO 14644-4:2022 design guidance. It sets the limits on how much bioburden can be put on the pre-filtration component. The goal is to ensure long term operation with low-power consumption.

High-Risk Zones and Layered Defense

When supplying air to the Grade A zones or sterilizing tunnels/ovens, the EU GMP standard requires HEPA filters for all incoming air. The healthiness of the filters is checked before and after certain applications. It is a much more layered approach in comparison to the FDA. The US standard relies on supplying clean air while ensuring positive pressure.

Hazardous Material

When manufacturing hazardous drug scenarios like the FDA <800>, both regulators require a once through approach to air circulation. The EU Annex 1 requires that your air filtration plan be linked to the master pollution prevention plan. It ensures that the facility is always ready for an audit.

Filter Selection

US regulation provides more freedom when selecting equipment. The FDA explicitly permits the use of finer ultra-low penetration air (ULPA) filters. EDU GMP does not provide any guidelines for its use.

Cleanroom Air Flow

Air Speed Limits

The most sensitive ISO 5 zones must have air traveling in a straight, unidirectional airflow. They sweep away contaminants from the product. To ensure a clean cleanroom, the FDA sets the air speed requirement at 0.45 meters per second, allowing 20% margin of error. EU GMP Annex 1 sets a 0.36 to 0.54 meters per second window for operation. The facilities will also have to defend the speeds during the initial setup and testing.

Visualizing Air Currents

European regulation requires a video reading of airflow studies. It needs to be performed while the room is at rest or when it's fully active in operation states. The video shows workers performing tasks to ensure dirt is being pulled and no ingress from lower grades. The FDA focuses on dynamic smoke studies and focuses on turbulence/eddy prevention.

Mixed Airflow

In critical zones, air flow needs to be strictly unidirectional and laminar as per both regulations. However, turbulent flow where swirling happens is allowed in less sensitive areas. The FDA allows mixed airflow in supporting areas. The EU allows turbulent flow in EU Grade C/D or closed isolators. It's only allowed if a risk assessment is performed and no contamination risk is involved.

Testing with Active Personnel

FDA requires testing with people and machinery working (dynamic conditions). The primary goal is to ensure that the sweeping action of the airflow still works. The EU Annex 1 introduced a human-factor control. They require proof that air flow protects the product despite interventions. Moreover, the tools and methods used to check the airflow should not disturb the air current itself.

Air Speed and Particle Data

Both regulatory standards require that the facilities using cleanrooms should mathematically link air velocity with particle counts. EU GMP requires that the recovery testing and historical data must correlate with it. It ensures that the system is working as intended by design.

Cleanroom Structural

Surface and Plumbing

The core goal is to ensure that the dirt and particles do not have a place to hide in cleanrooms. The US and Europe both require floors, walls, and ceilings to be made with perfectly flat, liquid-resistant, and unbroken surfaces. The intersections between the floor and walls should have covered junctions to ensure dust doesn't have a corner to set in.

European rules have strict rules for plumbing. There is a complete ban on washing stations and water drains in Grade A/B cleanrooms. There is a heavy limit on the use of sliding doors. The material selection is much stricter in comparison to the FDA allowance of drains in ISO 8 areas.

Fixtures and Chemical Durability

The FDA requires that all plumbing and hardware be designed for easy cleaning. There should be no extra shelves, sills, or protruding lights that could block or disrupt the unidirectional flow. In the case of EU GMP, the physical material used to build the room must be proven to withstand certain conditions. They should withstand repeated sporicidal disinfection without degradation.

Ceiling Integrity and Hidden Spaces

The EU and the FDA require the roof of the cleanroom to be airtight. The EU GMP specifically states that the design must prevent dirty air or dust from leaking down. The mechanical space should not seep in contaminants. The locking mechanisms of the ceiling should result in a grid lock together.

Entryways and Air Pressure

To ensure that the pressure cascades in cleanrooms is maintained, EU GMP requires interlock airlocks. The doors of the airlock in the Grade A/B cleanroom should not allow both doors to open at the same time. US FDA requires transitional rooms to general airlock separation. There is no requirement for interlocking mechanisms.

Room Layout, Worker Movement, and Cleaning

Both regulators want the workers to use ergonomics and ensure minimal personnel/material transfers into the cleanrooms. The EU ensures a holistic risk-based framework by connecting structural layout, barrier technologies, and the CCS plan. They demand detailed premises requirements, such as no recesses and cleanability utility penetrations.

The FDA focuses on equipment separation and ensuring that everything is easy to wash. The rules are governed under legal codes like 21 CFR 211.63/211.67. It allows more freedom for office builders.

Setup and Power Usage

FDA formally recognizes ISO 14644-4:2022, which dictates that the physical blueprints must have explicit checklists for startup and verification. Builders should have an energy-management consideration throughout the cleanroom life cycle. It's a forward-looking standard for modular and portable cleanrooms.

Table: Particle Limits Comparison (≥0.5 μm/m³) - Adapted from EU Annex 1 (2022) and FDA ISO-referenced classes

Summary

The FDA cGMP and EU GMP Annex 1 (2022) both use ISO 14644 classification, but differ in their application. The FDA focuses on ensuring compliance through testing with people and machinery actively working inside it. The EU takes a strict approach by risk-based CCS linking HVAC, filtration, and structural elements with continuous monitoring and visualization.

For a cleanroom manufacturer that exports to both the EU and the US region, compliance with these regulatory requirements is necessary. Their modular cleanrooms should have the right features to support operation, testing, and maintenance as per these regulatory guidelines.

If you are looking for a manufacturer that produces tailored modular and prefab cleanrooms, then consider SZ Pharma. They offer GMP compliant HVAC, filtration, and structural systems. They have more than a decade of experience and a veteran workforce that ensures compliance at every level. Contact SZ Pharma at:

• Telephone: +86-18241958031 / +86-19824886686
• Fax: 86-512-65488640
• Email: pharma@sz-pharma.com
• Whatsapp/Wechat: 008618241958031